REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 55 filers reported holding REPLIMUNE GROUP INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,781,000 | +4810.4% | 215,930 | +8495.9% | 0.00% | – |
| Q1 2021 | $77,000 | -93.9% | 2,512 | -91.7% | 0.00% | -100.0% |
| Q4 2020 | $1,265,000 | +19.8% | 30,185 | -27.8% | 0.00% | 0.0% |
| Q3 2020 | $1,056,000 | +16.8% | 41,831 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $904,000 | +72.5% | 41,148 | -23.3% | 0.00% | 0.0% |
| Q1 2020 | $524,000 | -43.4% | 53,677 | -16.8% | 0.00% | 0.0% |
| Q4 2019 | $926,000 | +6514.3% | 64,534 | +6245.5% | 0.00% | – |
| Q3 2019 | $14,000 | 0.0% | 1,017 | +3.4% | 0.00% | – |
| Q2 2019 | $14,000 | +1300.0% | 984 | +2136.4% | 0.00% | – |
| Q1 2019 | $1,000 | -83.3% | 44 | -92.9% | 0.00% | – |
| Q4 2018 | $6,000 | -33.3% | 619 | +10.1% | 0.00% | – |
| Q3 2018 | $9,000 | – | 562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |